BOSTON, Dec. 20 /PRNewswire-USNewswire/ -- "Reducing Cardiometabolic
Risk: What Are The Barriers?" a roundtable debate featuring the
chairpersons of the 2006 Cardiometabolic Health Congress (CHC), identified
the combined impact of obesity, diabetes and cardiovascular disease as the
biggest health problem facing the world today. Early
intervention/prevention, reimbursement and societal changes are cited as
critical for making significant progress.
Cardiometabolic risk (CMR) factors are associated with four of the top
10 leading causes of death -- heart disease, diabetes, stroke and cancer.
CMR is comprised of a set of risk factors that viewed together, are good
indicators of a person's overall risk of developing heart disease and type
2 diabetes. These include: obesity, high LDL ("bad") cholesterol, high
blood fat (triglycerides), low HDL ("good") cholesterol, high blood
pressure, smoking and physical inactivity.
The full discussion, which includes their proposed changes to improve
outcomes, is now available in audio and written transcript at
The CHC chairpersons are:
* Jay S. Skyler, MD, MACP, Professor of Medicine, University of Miami
Miller School of Medicine. Dr. Skyler is an expert in diabetes research
and a key opinion leader in the field of endocrinology
* Christie M. Ballantyne, MD, Professor of Medicine, Baylor College of
Medicine. Dr. Ballantyne is a cardiologist and conducts research on
prevention and identifying risk factors for coronary heart disease
* Richard W. Nesto, MD, Associate Professor, Harvard Medical School. Dr.
Nesto is an interventional cardiologist and clinical researcher on
diabetes, insulin resistance and coronary disease
Key points raised by Congress Chairpersons drove the debate towards the
"Obesity has been adopted as a risk factor yet relatively few
practitioners look at obesity as something that needs an intervention. As a
society we need to change the mindset that weight loss should be
cosmetically driven, not medically driven."
"Overweight and obesity are on the rise thereby increasing the
incidence of diabetes and cardiovascular disease at an alarming rate. We
must adapt early intervention strategies to treat all critical risk
"Getting diabetes when you're 20 is a new phenomenon ... people in
their 40s are going to end up with cardiovascular, kidney and eye disease
cost to society is going to be extraordinary. We should no longer wait
until end-stage disease to make an impact."
"Even when we go to put the lifestyle systems in place, we don't get
the reimbursement to support or sustain them."
To download the audio file of this roundtable or view the complete
written transcript, please visit cardiometabolichealth.org. For interview
requests, please contact GinaMarie Mangiaracina / Chandler Chicco Agency /
202-609-6003 or email@example.com.
SOURCE Cardiometabolic Health Congress